Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Closed
This trial is looking at having a drug called azacitidine after a stem cell transplant.
It is for people who are having a with somebody else’s cells. This is called an .
Recruitment start: 4 June 2019
Recruitment end: 27 March 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Charles Craddock
Birmingham University
IMPACT Partnership
Last reviewed: 5 April 2023
CRUK internal database number: 16166